First Eagle Investment Management
NVAX icon

First Eagle Investment Management’s Novavax NVAX Stock Holding History

First Eagle Investment Management’s Portfolio NVAX Stock Details NVAX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2014
Q4 		– Sell
-25,000
Closed -$2.08M – 350
2014
Q3 		$2.08M Hold
25,000
– – 0.01% 209
2014
Q2 		$2.31M Buy
25,000
+15,000
+150% +$1.32M 0.01% 211
2014
Q1 		$906K Sell
10,000
-30,000
-75% -$3.35M ﹤0.01% 213
2013
Q4 		$4.1M Hold
40,000
– – 0.01% 174
2013
Q3 		$2.53M Buy
+40,000
New +$2.25M 0.01% 193

Other funds holding NVAX

Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return
BFA
BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return
BB
BB Biotech Schaffhausen, Switzerland $3.98B AUM 15.47% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Wells Fargo
Wells Fargo San Francisco, California $617B AUM 30.33% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
BIT
BlackRock Institutional Trust San Francisco, California $675B AUM 16.07% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return

First Eagle Investment Management's NVAX Position: Q4 2014 in Review

First Eagle Investment Management sold out of Novavax (NVAX) in Q4 2014, closing a stake of 25,000 shares — an estimated $2.08M sold.

First Eagle Investment Management first reported a position in NVAX in Q3 2013 and held it in 5 quarters. The position peaked at $4.1M in Q4 2013. 153 funds tracked by Wall St. Rank hold NVAX as of Q4 2014.

  • First Eagle Investment Management reported no remaining Novavax position as of Q4 2014 after selling out during the quarter.
  • First Eagle Investment Management sold 25,000 Novavax shares in Q4 2014, an estimated $2.08M.
  • First Eagle Investment Management first reported a position in Novavax in Q3 2013 and held it in 5 quarters.
  • First Eagle Investment Management's Novavax position peaked at $4.1M in Q4 2013.
  • 153 funds tracked by Wall St. Rank held Novavax as of Q4 2014.

Based on First Eagle Investment Management's 13F filing for Q4 2014, filed 9 Feb 2015.